Loading...

LFCR LIFECORE BIOMEDICAL INC Accounting Changes 8-K Filing

LFCR

LFCR

LIFECORE BIOMEDICAL INC

(LFCR)

2023 8-K

Show Summary

Summary

Stockholder Meeting

Financial Results

Share Issuance Proposal

Financial Results

Credit Agreement Amendments

Investor Presentation

Annual Meeting Results

Stock Sale Agreement

Director Changes

Compliance Regained

Financial Results

Incentive Plan Approval

Workforce Reduction Plan

Cooperation Agreements

Equity Awards and Managemen...

Credit Agreement Amendment

Agreement Amendment, Annual...

Amendment to Incentive Plan

Accountant Engagement

Delisting Notice

Financial Update

Change in Registrant's Cert...

Financial Results

Delisting Notice

Agreement Amendments and Ma...

Regulatory Action

Restatement of Financial St...

Delisting Notice

Financial Results Announcement

Financial Results Announcement

Agreements with Alcon Resea...

Departure of Directors or C...

Delisting Notice

Sale of O Olive business

Financial Results and Strat...

Salary Increase

Disposition of Assets

Accounting restatement

Agreement and Amendments

External Links:

Lifecore Biomedical has identified errors in its previously issued financial statements and will be restating them, but does not expect adverse effects on operations or liquidity.

AI Assistant

LIFECORE BIOMEDICAL INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.